Bolt Biotherapeutics Stock

Bolt Therapeutics plans to develop a novel format for T-cell mediated anti-tumour therapy.

About Bolt Biotherapeutics Stock

Bolt Therapeutics plans to develop a novel format for T-cell mediated anti-tumour therapy.

Funding History

March 2015	$600K
September 2016	$10.0M
August 2018	$19.4M
February 2019	$54.0M

Management

President and CEO

Reiner Laus

Chief Business Officer

Grant Yonehiro

Chief Executive Officer and Director

CP Liu

Founder

Edgar Engleman

Other Companies

Learn More

Click Therapeutics

Click Therapeutics engineers, validates, and commercializes Digital Therapeutics™ applications

Baby health technology company

Precision Medicine Solutions Company

5Age (years)

$620MTotal Funding

Learn More

V7 creates deep learning models to learn to perform life sciences experiments and double the pace of critical scientific research.

2Age (years)

$0Total Funding

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Bolt Biotherapeutics or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Trending Companies

Join 110K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Why EquityZen?

EquityZen helps investors to access private companies and their employees to sell shares.

Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. Investors must be able to afford the loss of their entire investment. See our Risk Factors for a more detailed explanation of the risks involved by investing through EquityZen’s platform.

EquityZen Securities LLC (“EquityZen Securities”) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the Securities Exchange Commission and is a FINRA/SIPC member firm.

Equity securities are offered through EquityZen Securities. Check the background of this firm on FINRA’s BrokerCheck.

EquityZen.com is a website operated by EquityZen Inc. ("EquityZen"). By accessing this site and any pages thereof, you agree to be bound by our Terms of Use.
EquityZen and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.
© 2020 EquityZen Inc. All rights reserved.